In-home palliative care for dementia patients
Palliative Care At Home for Patients with Dementia and Their Caregivers
This study is testing a new in-home care program for people with advanced dementia to see if it helps improve their symptoms and quality of life while also supporting their family caregivers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05749146 on ClinicalTrials.gov |
What this trial studies
This trial evaluates a new model of in-home palliative care for patients with advanced dementia and their family caregivers. Participants will be randomized to receive either the intervention or an augmented control, with the intervention including a comprehensive intake visit and ongoing support from a clinical team. The study aims to assess the impact on patients' symptoms, quality of life, healthcare utilization, and caregiver burden. The trial will take place across multiple sites in New York City, focusing on personalized care plans and monitoring.
Who should consider this trial
Good fit: Ideal candidates include individuals aged over 64 with advanced dementia, a family caregiver, and residing in Manhattan.
Not a fit: Patients without a family caregiver or those living in long-term care facilities may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and care satisfaction for dementia patients and their caregivers.
How similar studies have performed: Other studies have shown promise in palliative care models for dementia, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * have advanced dementia, based on Global Deterioration Score (GDS)\>6 * impairment in at least one activity of daily living (ADL -which is inherent in this level of GDS) * at least one hospitalization or ED visit within the last 12 months * a physician who is primarily responsible for their dementia-related care whose clinical outpatient site is associated with one of the four Mount Sinai sites in Manhattan * a family caregiver willing to enroll * a residence in Manhattan where they are currently living (not in a long-term care facility) * capacity to consent or a legal representative available to provide consent * fluency in English or Spanish, or their legal representative must be fluent in English or Spanish * age \>64. Exclusion Criteria: * Does not have a family caregiver to enroll * Does not reside in Manhattan outside of long-term care facility * Does not have fluency in English or Spanish Doesn't
Where this trial is running
New York, New York
- Ichan School of Medicine at Mount Sinai — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Laura P Gelfman, MD, MPH — Icahn School of Medicine at Mount Sinai
- Study coordinator: Christian Espino
- Email: Christian.Espino@mssm.edu
- Phone: (212) 421-4632
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.